{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:13:41Z","timestamp":1790334821695,"version":"4.1.0"},"reference-count":104,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ijwd.2019.04.021","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T08:09:17Z","timestamp":1554883757000},"page":"141-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Clinical considerations for the management of psoriasis in women"],"prefix":"10.1097","volume":"5","author":[{"given":"Alice B.","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitriona","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny E.","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijwd.2019.04.021_bb0005","author":"American Pregnancy Association"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/1203475415572797","article-title":"Reasons for treatment changes in patients with moderate to severe psoriasis","volume":"19","author":"Anderson","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052935","article-title":"Quality of life and work productivity impairment among psoriasis patients: Findings from the National Psoriasis Foundation survey data 2003-2011","volume":"7","author":"Armstrong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0020","series-title":"Protopic [prescribing information]","author":"Astellas Pharma","year":"2011"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-0770","article-title":"Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany","volume":"90","author":"Augustin","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2011.07.039","article-title":"Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation","volume":"67","author":"Bae","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0035","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2133.2010.09899.x","article-title":"Potentially modifiable risk factors for adverse pregnancy outcomes in women with psoriasis","volume":"163","author":"Bandoli","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0040","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJMp1109283","article-title":"Shared decision making--pinnacle of patient-centered care","volume":"366","author":"Barry","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0045","first-page":"183","article-title":"Pregnancy outcome in women with psoriasis","volume":"53","author":"Ben-David","year":"2008","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0050","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3899\/jrheum.171218","article-title":"The effect of pregnancy on disease activity in patients with psoriatic arthritis","volume":"45","author":"Berman","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0055","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.14547","article-title":"Psoriasis and adverse pregnancy outcomes: A systematic review of observational studies","volume":"175","author":"Bobotsis","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0060","series-title":"ACR\/ARHP Annual Meeting","first-page":"969","article-title":"Obstetric outcomes in women with psoriatic arthritis: Results from nationwide inpatient sample database 2003-2011","author":"Boddeda","year":"2018"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-4362.1996.tb01632.x","article-title":"Psoriasis and pregnancy: Hormone and immune system interaction","volume":"35","author":"Boyd","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0075","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2340\/00015555-2923","article-title":"Effect of maternal psoriasis on pregnancy and birth outcomes: A population-based cohort study from Denmark and Sweden","volume":"98","author":"Broms","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0080","doi-asserted-by":"crossref","first-page":"417.e1","DOI":"10.1016\/j.jaad.2013.09.009","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation","volume":"70","author":"Butler","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0085","article-title":"Psoriasis is significantly associated with lower rates of pregnancy and live births","volume":"66","author":"Cather","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0090","doi-asserted-by":"crossref","first-page":"571912","DOI":"10.1155\/2013\/571912","article-title":"Psoriasis: Female skin changes in various hormonal stages throughout life--puberty, pregnancy, and menopause","volume":"2013","author":"Ceovic","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0095","first-page":"375","article-title":"Pregnancy outcomes in women exposed to etanercept: The OTIS Autoimmune Diseases in Pregnancy Project","volume":"103","author":"Chambers","year":"2015","journal-title":"Birth Defects Res A"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0100","doi-asserted-by":"crossref","first-page":"v34","DOI":"10.1093\/rheumatology\/key081","article-title":"Approach to evaluating pregnancy safety of anti-rheumatic medications in the OTIS MotherToBaby pregnancy studies: What have we learned?","volume":"57","author":"Chambers","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0105","first-page":"3636","article-title":"Birth outcomes following pregnancy exposure to adalimumab: The OTIS Autoimmune Diseases in Pregnancy Project","volume":"26","author":"Chambers","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2133.2011.10513.x","article-title":"Evidence-based (S3) guideline on topical corticosteroids in pregnancy","volume":"165","author":"Chi","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0115","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jamadermatol.2013.5768","article-title":"Pregnancy outcomes after maternal exposure to topical corticosteroids: A UK population-based cohort study","volume":"149","author":"Chi","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007346.pub3","article-title":"Safety of topical corticosteroids in pregnancy","author":"Chi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0125","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/annrheumdis-2017-211384","article-title":"Minimal to no transfer of certolizumab pegol into breast milk: Results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study","volume":"76","author":"Clowse","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0130","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/art.40508","article-title":"Pregnancy outcomes after exposure to certolizumab pegol: Updated results from a pharmacovigilance safety database","volume":"70","author":"Clowse","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0135","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1468-3083.2010.03917.x","article-title":"Pregnancy outcomes in women with moderate-to-severe psoriasis","volume":"25","author":"Cohen-Barak","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0140","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/492S50a","article-title":"Psoriasis uncovered","volume":"492","author":"Crow","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0145","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijwd.2015.03.001","article-title":"The immunologic effects of estrogen on psoriasis: A comprehensive review","volume":"1","author":"Danesh","year":"2015","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10103-011-0895-0","article-title":"Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis","volume":"26","author":"El-Saie","year":"2011","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0155","author":"European Medicines Agency"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0160","author":"European Medicines Agency"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0165","author":"European Medicines Agency"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0170","author":"European Medicines Agency"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0175","series-title":"Salvax [prescribing information]","author":"Exeltis USA Dermatology","year":"2016"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0180","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/rheumatology\/kev404","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: Standard and biologic disease modifying anti-rheumatic drugs and corticosteroids","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0185","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/rheumatology\/kev405","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: Analgesics and other drugs used in rheumatology practice","volume":"55","author":"Flint","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0190","author":"G&W Laboratories"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0195","first-page":"203","article-title":"Sex differences in the treatment of psoriatic arthritis: A systematic literature review","volume":"18","author":"Generali","year":"2016","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0200","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"Gotestam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0205","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bpobgyn.2008.06.010","article-title":"Teamwork in obstetric critical care","volume":"22","author":"Guise","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-4362.1997.00032.x","article-title":"Psoriasis and sex: a study of moderately to severely affected patients","volume":"36","author":"Gupta","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0215","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/jid.2014.35","article-title":"No increased risk of fetal death or prolonged time to pregnancy in women with psoriasis","volume":"134","author":"Harder","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0220","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jaad.2016.10.040","article-title":"Lesions on the back of hands and female gender predispose to stigmatization in patients with psoriasis","volume":"76","author":"Hawro","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0225","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1365-4632.2011.05445.x","article-title":"Caring for new mothers: diagnosis, management and treatment of nipple dermatitis in breastfeeding mothers","volume":"51","author":"Heller","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0230","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar3227","article-title":"Managing pregnancy in inflammatory rheumatological diseases","volume":"13","author":"Jain","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051349","article-title":"The use and safety of TNF inhibitors during pregnancy in women with psoriasis: A review","volume":"19","author":"Johansen","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0240","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/acr.22516","article-title":"Proceedings from the American College of Rheumatology Reproductive Health Summit: The management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases","volume":"67","author":"Kavanaugh","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0245","author":"Kieler"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bjd.13013","article-title":"Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)","volume":"171","author":"Kimball","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2016.11.004","article-title":"Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-alpha use in females with immune mediated diseases; a systematic review and meta-analysis","volume":"76","author":"Komaki","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0378-6323.125472","article-title":"Prevalence and clinical patterns of psoriatic arthritis in Indian patients with psoriasis","volume":"80","author":"Kumar","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0265","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","article-title":"The prevalence of previously diagnosed and undiagnosed psoriasis in U.S. adults: Results from NHANES 2003-2004","volume":"60","author":"Kurd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0270","first-page":"891","article-title":"The risk of depression, anxiety, and suicidality in patients with psoriasis: A population-based cohort study","volume":"146","author":"Kurd","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0275","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1590\/S0482-50042012000600011","article-title":"Sexual dysfunction in patients with psoriasis and psoriatic arthritis--a systematic review","volume":"52","author":"Kurizky","year":"2012","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0280","series-title":"Intl Fed Psoriasis Assoc","first-page":"34369","article-title":"A comprehensive survey assessing the family planning needs of women with psoriasis","author":"Lebwohl","year":"2018"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0285","first-page":"PSS34","article-title":"The prevalence and treatment patterns of women of child bearing age (WoCBA) with psoriasis (PSO)","volume":"21","author":"Lee","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.ijwd.2019.04.021_bb9100","first-page":"10546","article-title":"Incidence of peri-pregnancy flares among psoriasis patients","author":"Lee","year":"2019","journal-title":"Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0290","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1741-7015-10-82","article-title":"Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: An observational study","volume":"10","author":"Lesuis","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0295","author":"LEO Innovation Lab and The Happiness Research Institute"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0300","author":"LEO Laboratories"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0022-3859.30334","article-title":"Psoriatic arthritis as a distinct disease entity","volume":"53","author":"Leung","year":"2007","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0310","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.mcna.2009.08.003","article-title":"Evaluation and management of psoriasis: An internist's guide","volume":"93","author":"Levine","year":"2009","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0315","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/jid.2011.271","article-title":"The impact of psoriasis on pregnancy outcomes","volume":"132","author":"Lima","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0320","doi-asserted-by":"crossref","first-page":"S588","DOI":"10.1016\/S0016-5085(18)32145-0","article-title":"Su1799 \u2013Pregnancy outcomes in women exposed to ustekinumab","volume":"154","author":"Mahadevan","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0325","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","article-title":"Lack of placental transfer of certolizumab pegol during pregnancy: Results from CRIB, a prospective, postmarketing, pharmacokinetic study","volume":"77","author":"Mariette","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0330","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2018.05.040","article-title":"Exposure concentrations of infants breastfed by women receiving biologic therapies for inflammatory bowel diseases and effects of breastfeeding on infections and development","volume":"155","author":"Matro","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0335","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3899\/jrheum.130797","article-title":"Depression and anxiety in psoriatic disease: Prevalence and associated factors","volume":"41","author":"McDonough","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0340","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","article-title":"Managing patients with psoriatic disease: The diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis","volume":"74","author":"Mease","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0345","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1365-2133.2011.10249.x","article-title":"Quality of life and sexual health in patients with genital psoriasis","volume":"164","author":"Meeuwis","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0350","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0355","author":"MotherToBaby"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0360","author":"MotherToBaby"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0365","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3899\/jrheum.160929","article-title":"Pregnancy outcomes in patients with psoriatic arthritis","volume":"44","author":"Mouyis","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0370","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archderm.141.5.601","article-title":"Hormonal effect on psoriasis in pregnancy and post partum","volume":"141","author":"Murase","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0375","article-title":"Fears and misconceptions of women with chronic inflammatory diseases on their journey to motherhood","volume":"8060","author":"Murase","year":"2019","journal-title":"Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0380","doi-asserted-by":"crossref","first-page":"401.e1","DOI":"10.1016\/j.jaad.2013.09.010","article-title":"Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy","volume":"70","author":"Murase","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0385","author":"PlaquePsoriasis.com"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0390","series-title":"The skin you're in","author":"National Psoriasis Foundation","year":"2017"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0395","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.semarthrit.2017.01.002","article-title":"Psoriatic arthritis disease activity during pregnancy and the first-year postpartum","volume":"46","author":"Polachek","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0400","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/bjd.15802","article-title":"Exposure to biological therapies during conception and pregnancy: A systematic review","volume":"178","author":"Pottinger","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb9200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijwd.2016.12.003","article-title":"Update on biologic safety for patients with psoriasis during pregnancy","volume":"3","author":"Porter","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0405","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/ajd.12641","article-title":"Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration","volume":"59","author":"Rademaker","year":"2018","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0410","series-title":"Presented at RheumaPreg 2018 [OP07]","article-title":"Pregnancy and birth outcomes in women with psoriatic arthritis, a nation-wide Swedish cohort study, 2007\u20132014","author":"Remaeus","year":"2018"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0415","article-title":"Anti-TNF treatments for women with chronic inflammatory diseases: Comparing attitudes and perceptions of physicians in Europe and the US","volume":"845","author":"Ryan","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0420","doi-asserted-by":"crossref","first-page":"97883","DOI":"10.1016\/j.jaad.2015.02.1127","article-title":"Genital psoriasis is associated with significant impairment in quality of life and sexual functioning","volume":"72","author":"Ryan","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0425","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7525-7-25","article-title":"The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: A comparison with a selected sample of healthy people","volume":"7","author":"Salaffi","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0430","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000096910","article-title":"Pregnancy and pregnancy outcome among women with inflammatory skin diseases","volume":"214","author":"Seeger","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0435","article-title":"An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies","volume":"12","author":"Singh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0440","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjd.15665","article-title":"British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017","volume":"177","author":"Smith","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0445","series-title":"ACR\/ARHP Annual Meeting","first-page":"2431","article-title":"Birth outcomes and disease activity during pregnancy in a prospective cohort of women with psoriatic arthritis and ankylosing spondylitis","author":"Smith","year":"2018"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0450","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/1203475417724438","article-title":"Treatment changes in patients with moderate to severe psoriasis: A retrospective chart review","volume":"22","author":"Smith","year":"2018","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0455","series-title":"Drithocreme [prescribing information]","author":"Summer Laboratories","year":"2006"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0460","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2133.1997.tb01555.x","article-title":"Genetic counselling in psoriasis: Empirical data on psoriasis among first-degree relatives of 3095 psoriatic probands","volume":"137","author":"Swanbeck","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0465","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/120347540200600608","article-title":"Psoriasis and pregnancy","volume":"6","author":"Tauscher","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.ijwd.2019.04.021_bb9300","series-title":"Tazorac. [prescribing information]","author":"Allergan","year":"2017"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0470","series-title":"Adalimumab (Humira) prescribing information [Internet]","author":"U.S. Food and Drug Administration","year":"2008"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0475","series-title":"Certolizumab pegol (Cimzia) prescribing information [Internet]","author":"U.S. Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0480","article-title":"Disease activity of psoriatic arthritis during and after pregnancy: A prospective multicenter study","author":"Ursin","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0485","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1067\/mjd.2000.107501","article-title":"The burden of psoriasis: A study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms","volume":"43","author":"Wahl","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0490","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/bjd.16901","article-title":"Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database","volume":"179","author":"Warren","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0495","author":"World Health Organization"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0500","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2340\/00015555-2312","article-title":"Hormonal factors and risk of psoriasis in women: A cohort study","volume":"96","author":"Wu","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0505","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaad.2010.02.005","article-title":"Psoriasis and pregnancy outcomes: a nationwide population-based study","volume":"64","author":"Yang","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ijwd.2019.04.021_bb0510","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nchem.2629","article-title":"Materials and methods for delivery of biological drugs","volume":"8","author":"Zelikin","year":"2016","journal-title":"Nat Chem"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519300346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519300346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T14:26:00Z","timestamp":1641565560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647519300346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S2352647519300346"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.04.021","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical considerations for the management of psoriasis in women","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}